Long-term Serum Platinum Changes and Their Association with Cisplatin-related Late Effects in Testicular Cancer Survivors
Overview
Authors
Affiliations
Background: The long-term toxicities after cisplatin-based chemotherapy (CBCT) reveal a remarkable inter-individual variation among testicular cancer survivors (TCSs). Therefore, we assessed long-term platinum (Pt) changes and their associations with CBCT-related late effects in TCSs.
Material And Methods: In 77 TCSs treated with CBCT from 1984 to 1990, blood samples for analyses of Pt and a questionnaire including self-reported neuro- and ototoxicity (NTX) symptoms were collected during two follow-up surveys at median 12 (Survey I; SI) and 20 (Survey II; SII) years after treatment. Information about second cancers after SII was retrieved from the Norwegian Cancer Registry.
Results: A larger Pt decline from SI to SII was associated with a decreased risk of a second cancer diagnosis (HR 0.78, 95% CI 0.62-0.99 per 10 ng/L/year), and worsening of paresthesias in hands (OR 1.98, 95% CI 1.09-3.59 per 10 ng/L/year) and tinnitus (OR 1.51, 95% CI 1.01-2.27 per 10 ng/L/year).
Conclusion: In summary, we found a significant association between a larger Pt decline and a reduced risk of second cancers and deterioration of paresthesias in hands and tinnitus.
Breekveldt E, Ykema B, Huitema A, Gietema J, Beijnen J, Snaebjornsson P PLoS One. 2024; 19(11):e0312994.
PMID: 39541403 PMC: 11563357. DOI: 10.1371/journal.pone.0312994.
Coyne E, Dieperink K, Voltelen B, Barreto M, Garcia-Vivar C Support Care Cancer. 2024; 32(11):712.
PMID: 39377934 PMC: 11461586. DOI: 10.1007/s00520-024-08909-1.
Zaleskis G, Characiejus D, Jursenaite J, Zibutyte L, Kriauciunaite K, Vanagaite-Zickiene M In Vivo. 2022; 36(3):1106-1113.
PMID: 35478153 PMC: 9087100. DOI: 10.21873/invivo.12808.
Kvammen O, Myklebust T, Solberg A, Moller B, Klepp O, Fossa S PLoS One. 2019; 14(12):e0225942.
PMID: 31851716 PMC: 6919610. DOI: 10.1371/journal.pone.0225942.
Albrecht W Urologe A. 2019; 58(10):1212-1216.
PMID: 31324932 DOI: 10.1007/s00120-019-1000-8.